• Home
  • Stock
  • Marksans Pharma Fundamental Analysis
  • Marksans Pharma Fundamental Analysis

Marksans Pharma fundamental analysis

MARKSANS

HealthcareMid

185.79

2.01 (-1.07%)
Last updated on 6 Dec, 2025 | 14:05 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Marksans Pharma Fundamentals

P/E Ratio

23.7

P/B Ratio

3.1

Div. Yield

0.43

Sector P/E

36.18

Sector P/B

0.98

Sec. Div. Yield

0.56

  • Marksans Pharma Fundamentals is currently trading with a P/E Ratio of 23.7, compared to the sector average of 36.18. Its P/B Ratio stands at 3.1, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0.43%, which is than the sector’s 0.56%.

Marksans Pharma Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Marksans Pharma reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.